Interrelationship between fatty liver and insulin resistance in the development of type 2 diabetes
- PMID: 21252243
- PMCID: PMC3070249
- DOI: 10.1210/jc.2010-2190
Interrelationship between fatty liver and insulin resistance in the development of type 2 diabetes
Abstract
Context: Although fatty liver and insulin resistance are known to be associated, the relationship between the two in the development of type 2 diabetes mellitus (T2DM) is unclear.
Objective: We investigated the 5-yr risk of developing T2DM in individuals diagnosed with fatty liver using ultrasound and stratified by insulin sensitivity using quartiles of fasting insulin concentration.
Design and methods: We examined the clinical and laboratory data of 11,091 Koreans who had a medical evaluation including fasting insulin concentration and abdominal ultrasound at baseline and had a follow-up after 5 yr.
Results: At baseline, 27% of the population had fatty liver. Almost half (47%) of the individuals with fatty liver had baseline insulin concentration in the highest quartile compared with 17% in those without fatty liver (P < 0.001). Regardless of baseline insulin concentration, individuals with fatty liver had significantly (P < 0.001) more baseline clinical and metabolic abnormalities, including higher glucose and triglyceride concentration and lower high-density lipoprotein cholesterol concentration. In addition, regardless of baseline insulin concentration, individuals with fatty liver had a significantly increased risk for incident T2DM compared with those without fatty liver [crude odds ratio, 5.05 (95% confidence interval, 2.08-12.29) in the lowest insulin quartile and 6.34 (3.58-11.21) in the highest quartile]. In individuals in the highest insulin quartile, the odds ratio for developing T2DM remained significant even after multivariate adjustment including baseline glucose concentration [2.42 (1.23-4.75)].
Conclusion: Although associated with insulin resistance, fatty liver diagnosed by ultrasound appears to independently increase the risk of T2DM.
References
-
- Fan JG, Li F, Cai XB, Peng YD, Ao QH, Gao Y. 2007. Effects of nonalcoholic fatty liver disease on the development of metabolic disorders. J Gastroenterol Hepatol 22:1086–1091 - PubMed
-
- Kim CH, Park JY, Lee KU, Kim JH, Kim HK. 2008. Fatty liver is an independent risk factor for the development of type 2 diabetes in Korean adults. Diabet Med 25:476–481 - PubMed
-
- Yamada T, Fukatsu M, Suzuki S, Wada T, Yoshida T, Joh T. 2010. Fatty liver predicts impaired fasting glucose and type 2 diabetes mellitus in Japanese undergoing a health checkup. J Gastroenterol Hepatol 25:352–356 - PubMed
-
- Reaven GM. 1988. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595–1607 - PubMed
-
- Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR. 1992. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340:925–929 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
